Inventor · disambiguated record
Simon Shaw
Also filed as: SHAW SIMON · SHAW SIMON J · SHAW SIMON JAMES
42 granted patents·10 pending applications·198 citations·filing 2003–2025
97Inventor score
Top patents by PatentIndex Score
52 records- 0198US11479543B2Heterocyclic RIP1 kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Oct 25, 2022·5 cites·3 claims
- 0297US11407736B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·4 cites·8 claims
- 0397US10941134B2AMPK-activating heterocyclic compounds and methods for using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Mar 9, 2021·18 cites·20 claims
- 0497US10377742B2AMPK-activating heterocyclic compounds and methods for using the sameRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Aug 13, 2019·20 cites·21 claims
- 0596US11332451B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted May 17, 2022·3 cites·13 claims
- 0696US10815206B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·16 cites·17 claims
- 0795US8809370B2AMPK-activating heterocyclic compounds and methods for using the sameRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Aug 19, 2014·17 cites·7 claims
- 0895US8791136B2Substituted pyridine, pyridazine, pyrazine and pyrimidine compounds and methods for using the sameGOFF DANE·Filed 2011·Granted Jul 29, 2014·26 cites·27 claims
- 0994US11370787B2Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulationsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·4 cites·23 claims
- 1094US8987303B2AMPK-activating heterocyclic compounds and methods for using the sameRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Mar 24, 2015·16 cites·24 claims
- 1194US8980921B2AMPK-activating heterocyclic compounds and methods for using the sameRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Mar 17, 2015·16 cites·7 claims
- 1293US11377428B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jul 5, 2022·2 cites·13 claims
- 1393US11370765B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·2 cites·13 claims
- 1493US11370764B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·2 cites·13 claims
- 1593US9266856B2AMPK—activating heterocyclic compounds and methods for using the sameRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Feb 23, 2016·14 cites·30 claims
- 1689US9663496B2AMPK-activating heterocyclic compounds and methods for using the sameRIGEL PHARMACEUTICALS INC·Filed 2016·Granted May 30, 2017·9 cites·18 claims
- 1789US2025034100A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1888US11530194B2Amide compounds and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Dec 20, 2022·1 cites·24 claims
- 1987US2024368119A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2084US12116354B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2022·Granted Oct 15, 2024·0 cites·21 claims
- 2183US10947216B2Amide compounds and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Mar 16, 2021·1 cites·28 claims
- 2283US9409884B25- or 6-substituted benzofuran-2-carboxamide compounds and methods for using themRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Aug 9, 2016·4 cites·17 claims
- 2382US12331036B2Heterocyclic RIP1 kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2022·Granted Jun 17, 2025·0 cites·7 claims
- 2482US11939317B2Amide compounds and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2022·Granted Mar 26, 2024·0 cites·20 claims
- 2582US2025092057A1Heterocyclic rip1 inhibitory compoundsRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2681US12441723B2Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulationsRIGEL PHARMACEUTICALS INC·Filed 2023·Granted Oct 14, 2025·0 cites·19 claims
- 2781US12384775B2Pyrimid-2-yl-pyrazole compounds as IRAK inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2023·Granted Aug 12, 2025·0 cites·22 claims
- 2881US6939861B2Amido macrolidesKOSAN BIOSCIENCES INC·Filed 2003·Granted Sep 6, 2005·13 cites·10 claims
- 2980US2023112865A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3078US10414753B2Amide compounds and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Sep 17, 2019·1 cites·29 claims
- 3178US7214708B2Synthetic discodermolide analogsKOSAN BIOSCIENCES INC·Filed 2005·Granted May 8, 2007·2 cites·20 claims
- 3278US2025333408A1Pyrimid-2-yl-pyrazole compounds as irak inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3376US11472782B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Oct 18, 2022·0 cites·17 claims
- 3476US2023143161A1Heterocyclic rip1 inhibitory compoundsRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3575US12297202B2RIP1K inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2023·Granted May 13, 2025·0 cites·4 claims
- 3671US11578078B2Heterocyclic RIP1 inhibitory compoundsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Feb 14, 2023·0 cites·18 claims
- 3770US2022306620A1Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulationsRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3869US8193241B2Discodermolide analogues and methods of their useSMITH III AMOS B·Filed 2010·Granted Jun 5, 2012·2 cites·19 claims
- 3967US11667643B2RIP1K inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Jun 6, 2023·0 cites·19 claims
- 4065US2022098175A1Direct ampk activatorsRIGEL PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4164US12459941B2Tricyclic IRAK inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2023·Granted Nov 4, 2025·0 cites·13 claims
- 4263US2025019372A1Crystalline forms of a ripk1 inhibitorRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4363US2023310454A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4460US12357623B2Method for treating a disease or condition using a pyrazole compound or formulation thereofRIGEL PHARMACEUTICALS INC·Filed 2022·Granted Jul 15, 2025·0 cites·28 claims
- 4555US12156880B2Heterocyclic RIP1 kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2022·Granted Dec 3, 2024·0 cites·2 claims
- 4654US11564930B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jan 31, 2023·0 cites·55 claims
- 4754US7595300B27-quinolyl ketolide antibacterial agentsKOSAN BIOSCIENCES INC·Filed 2006·Granted Sep 29, 2009·0 cites·23 claims
- 4850US11174246B2Direct AMPK activatorsRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Nov 16, 2021·0 cites·33 claims
- 4948US7348436B2Compounds useful for the synthesis of (+)-discodermolide and methods thereofKOSAN BIOSCIENCES INC·Filed 2005·Granted Mar 25, 2008·0 cites·17 claims
- 5045US7582611B2Motilide compoundsPFIZER·Filed 2006·Granted Sep 1, 2009·0 cites·16 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →